Search Clinical Trials

589,087 trials

NCT07646015
Completed
Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic DisordersJSS Medical College Hospital
NCT07645196
Not Yet RecruitingNot Applicable
Effects of Physiotherapy on Ultrasound and Clinical Parameters in Women With DysmenorrheaVrije Universiteit Brussel
NCT07645833
Not Yet RecruitingPhase 3
Eptinezumab for Chronic Headache in Idiopathic Intracranial HypertensionH. Lundbeck A/S
NCT07643831
Unknown
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast CancerGenentech, Inc.
NCT07644728
Not Yet Recruiting
Sleep Quality and Biomarkers in Adolescent Girls With Anorexia NervosaUniversity Hospital of Split
NCT07644351
Completed
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia PatientsNovartis Pharmaceuticals
NCT07644091
Recruiting
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer PatientsMethodist Health System
NCT07644494
Completed
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: The Impact of Spontaneous Respiratory EffortJingyuan,Xu
NCT07646093
CompletedNot Applicable
Weight-Adjusted Diclofenac Potassium Medicated Lollipop for Post-Adenotonsillectomy Pain in ChildrenHospital Universitario de Caracas
NCT07645378
Not Yet RecruitingNot Applicable
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South AfricaCentre for the AIDS Programme of Research in South Africa
NCT07645469
Not Yet RecruitingPhase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer Center
NCT07645300
Not Yet RecruitingPhase 2
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Medical Center
NCT07644754
Not Yet RecruitingNot Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of Munich
NCT07645976
Completed
Home Environmental Risks and Caregiver AwarenessMarmara University Pendik Training and Research Hospital
NCT07646171
Recruiting
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)Tel-Aviv Sourasky Medical Center
NCT07645937
Not Yet RecruitingNot Applicable
Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple SclerosisDicle University
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07645781
Not Yet RecruitingNot Applicable
Cervical Stabilization Exercises IN Subacromial Impingement SyndromeCairo University
NCT07645118
Not Yet RecruitingPhase 2
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te Vuong
NCT07643922
Not Yet RecruitingNot Applicable
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageBeijing Tiantan Hospital